NEUROCRINE BIOSCIENCES INC Sale Leaseback Transaction, Deferred Gain, Net
NEUROCRINE BIOSCIENCES INC (NBIX) had Sale Leaseback Transaction, Deferred Gain, Net of $8.00 million as of 2018-12-31, per its 10-K filed 2020-02-07.
Discontinued › Notes › Leases
us-gaap:SaleLeasebackTransactionDeferredGainNet · last filed 2020-02-07
- 2018-12-31: Sale Leaseback Transaction, Deferred Gain, Net $8.00M; Sale Leaseback Transaction, Deferred Gain, Net as first filed $7.30M.
- 2018-09-30: Sale Leaseback Transaction, Deferred Gain, Net $8.20M.
- 2018-06-30: Sale Leaseback Transaction, Deferred Gain, Net $8.40M.
- 2018-03-31: Sale Leaseback Transaction, Deferred Gain, Net $8.60M.
| Period end | Sale Leaseback Transaction, Deferred Gain, Net | Sale Leaseback Transaction, Deferred Gain, Net as first filed |
|---|---|---|
| 2018-12-31 | $8.00M 10-K · filed 2020-02-07 | $7.30M 10-K · filed 2019-02-08 |
| 2018-09-30 | $8.20M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $8.40M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $8.60M 10-Q · filed 2018-04-30 | |
| 2017-12-31 | $8.80M 10-K · filed 2018-02-13 | |
| 2017-09-30 | $9.00M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $9.10M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $10.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $10.90M 10-K · filed 2017-02-14 | |
| 2016-09-30 | $11.80M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $12.60M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $13.50M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $14.30M 10-K · filed 2016-02-11 | |
| 2015-09-30 | $15.20M 10-Q · filed 2015-10-29 | |
| 2015-06-30 | $16.00M 10-Q · filed 2015-07-29 | |
| 2015-03-31 | $16.80M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $17.60M 10-K · filed 2015-02-09 | |
| 2014-09-30 | $18.50M 10-Q · filed 2014-11-04 | |
| 2014-03-31 | $20.10M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $20.90M 10-K · filed 2014-02-11 | |
| 2013-06-30 | $19.30M 10-Q · filed 2014-08-06 | |
| 2012-12-31 | $24.00M 10-K · filed 2013-02-08 | |
| 2008-12-31 | $39.10M 10-K · filed 2020-02-07 | |
| 2007-12-31 | $39.10M 10-K · filed 2013-02-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |